2-(3-((3-Fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

Ethyl 4-(2-nitrophenyl)thiazole-2-carboxylate, 95.0%, 100mg

1-Boc-3-Methanesulphonyloxypiperidine, 95.0%, 25g

B-D-GLUCOPYRANOSIDE, ETHYL 1-THIO-, 95%, 250mg

(2S)-2,3-DIHYDRO-2-METHYL-1H-INDOLE, 95.0%, 500mg

methyl (5S,8S,10aR)-5-(tert-butoxycarbonylamino)-6-oxo-2,3,4,5,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a][1,5]diazocine-8-carboxylate, 97, 5g

5-Bromo-1-methyl-1H-pyrrole-2-carboxylic acid, 95.0%, 5g

N,N-Dimethyldecanamide, 95.0%, 1kg

(2-[4-Benzyl-piperazin-1-yl]-2-oxo-ethyl)-carbamic acid tert-butyl ester, 5g

Weise tampón concentrado pH 7,2

2,6-DI-(BOC-AMINO)PYRIDINE, 95.0%, 1g

4,5-Methylenedioxy-1,2-phenylenediamine dihydrochloride, 98%, 10mg

Símbolo de advertencia según ISO 7010 Etiqueta individual, Sustancias tóxicas, Longitud lateral 200 mm, 1 pieza